On the public citation graph

A simple digital image analysis system for automated Ki67 assessment in primary breast cancer

https://doi.org/10.1111/his.14355
0 signed · 64 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s10549-013-2560-8openalex-snapshot
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
inferredcites →https://doi.org/10.1007/s10549-015-3559-0openalex-snapshot
Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
inferredcites →https://doi.org/10.1007/s10549-019-05163-6openalex-snapshot
Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach
inferredcites →https://doi.org/10.1016/j.breast.2013.11.007openalex-snapshot
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer
inferredcites →https://doi.org/10.1016/j.breast.2015.07.017openalex-snapshot
Strategies for developing Ki67 as a useful biomarker in breast cancer
inferredcites →https://doi.org/10.1016/j.breast.2016.11.016openalex-snapshot
POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen
inferredcites →https://doi.org/10.1016/j.cell.2011.02.013openalex-snapshot
Hallmarks of Cancer: The Next Generation
inferredcites →https://doi.org/10.1016/s1470-2045(09)70262-1openalex-snapshot
Ki67 in breast cancer: prognostic and predictive potential
inferredcites →https://doi.org/10.1016/s1470-2045(20)30458-7openalex-snapshot
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
inferredcites →https://doi.org/10.1038/bjc.2011.569openalex-snapshot
Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer
inferredcites →https://doi.org/10.1038/labinvest.2014.7openalex-snapshot
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue
inferredcites →https://doi.org/10.1038/modpathol.2015.38openalex-snapshot
An international study to increase concordance in Ki67 scoring
inferredcites →https://doi.org/10.1038/npjbcancer.2016.14openalex-snapshot
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration
inferredcites →https://doi.org/10.1038/s41379-018-0109-4openalex-snapshot
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
inferredcites →https://doi.org/10.1038/s41523-020-0168-9openalex-snapshot
Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic
inferredcites →https://doi.org/10.1038/sj.bjc.6603756openalex-snapshot
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
inferredcites →https://doi.org/10.1038/srep00503openalex-snapshot
Detection and Segmentation of Cell Nuclei in Virtual Microscopy Images: A Minimum-Model Approach
inferredcites →https://doi.org/10.1093/annonc/mdp234openalex-snapshot
Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)
inferredcites →https://doi.org/10.1093/annonc/mdq738openalex-snapshot
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
inferredcites →https://doi.org/10.1093/jnci/djr393openalex-snapshot
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
inferredcites →https://doi.org/10.1093/jncimonographs/lgr034openalex-snapshot
Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast Cancer
inferredcites →https://doi.org/10.1097/pai.0b013e31817af2cfopenalex-snapshot
MIB-1 Cell Membrane Reactivity: A Finding That Should be Interpreted Carefully
inferredcites →https://doi.org/10.1111/his.13880openalex-snapshot
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration
inferredcites →https://doi.org/10.1111/j.1365-2559.2006.02514.xopenalex-snapshot
Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment I
inferredcites →https://doi.org/10.1136/jcp.2010.077578openalex-snapshot
Comparative validation of the SP6 antibody to Ki67 in breast cancer
inferredcites →https://doi.org/10.1155/2014/390618openalex-snapshot
Endocrine Resistance in Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-1283openalex-snapshot
Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study
inferredcites →https://doi.org/10.1158/1538-7445.sabcs17-gs1-03openalex-snapshot
Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)
inferredcites →https://doi.org/10.1186/1472-6890-11-3openalex-snapshot
Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer
inferredcites →https://doi.org/10.1186/1745-6215-14-261openalex-snapshot
WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
inferredcites →https://doi.org/10.1186/1746-1596-8-34openalex-snapshot
CognitionMaster: an object-based image analysis framework
inferredcites →https://doi.org/10.1186/bcr2719openalex-snapshot
Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer
inferredcites →https://doi.org/10.1186/s13058-019-1223-zopenalex-snapshot
Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients
inferredcites →https://doi.org/10.1186/s13058-020-01264-zopenalex-snapshot
MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth
inferredcites →https://doi.org/10.1200/jco.2006.09.6578openalex-snapshot
A Phase II Placebo-Controlled Trial of Neoadjuvant Anastrozole Alone or With Gefitinib in Early Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2007.11.9453openalex-snapshot
Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98
inferredcites →https://doi.org/10.1200/jco.2016.69.4406openalex-snapshot
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
inferredcites →https://doi.org/10.1309/qphd-rb00-qxgm-uq9nopenalex-snapshot
Minimum Formalin Fixation Time for Consistent Estrogen Receptor Immunohistochemical Staining of Invasive Breast Carcinoma
inferredcites →https://doi.org/10.1371/journal.pone.0037379openalex-snapshot
How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
inferredcites →https://doi.org/10.1371/journal.pone.0188983openalex-snapshot
The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer
inferredcites →https://doi.org/10.3390/cancers4030725openalex-snapshot
Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Pathological Characteristics

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/hsr2.70412openalex-snapshot
Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review
inferred← citeshttps://doi.org/10.1002/path.6163openalex-snapshot
Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects
inferred← citeshttps://doi.org/10.1007/s00428-026-04500-7openalex-snapshot
Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identification
inferred← citeshttps://doi.org/10.1007/s12672-025-02233-8openalex-snapshot
Ki-67 and 21-gene recurrence score assay in decision making for adjuvant chemotherapy in breast cancer patients
inferred← citeshttps://doi.org/10.1016/j.colsurfa.2026.140813openalex-snapshot
Sodium alginate hydrogel‑mediated local chemotherapy: A synergistic strategy for breast cancer therapy and postoperative wound repair
inferred← citeshttps://doi.org/10.1016/j.jpi.2022.100100openalex-snapshot
A digital method to interpret the C-MYC stain in diffuse large B cell lymphoma
inferred← citeshttps://doi.org/10.1016/j.mpdhp.2022.08.001openalex-snapshot
Bench to bedside: research influencing clinical practice in breast cancer
inferred← citeshttps://doi.org/10.1016/j.sciaf.2024.e02308openalex-snapshot
Protein biomarkers for diagnosis of breast cancer
inferred← citeshttps://doi.org/10.1016/j.vetpar.2025.110548openalex-snapshot
Dopaminergic neuropathology in calves naturally infected with Neospora caninum
inferred← citeshttps://doi.org/10.1038/s41379-022-01055-1openalex-snapshot
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring
inferred← citeshttps://doi.org/10.1038/s41523-025-00745-8openalex-snapshot
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention
inferred← citeshttps://doi.org/10.1038/s41698-026-01414-0openalex-snapshot
Validation of QuANTUM-derived tumor cell fraction for molecular testing in high-grade serous tubo-ovarian carcinoma
inferred← citeshttps://doi.org/10.1109/bibm55620.2022.9995030openalex-snapshot
MVSF: Multi-View Signature Fusion Network for Noninvasively Predicting Ki67 Status
inferred← citeshttps://doi.org/10.1111/his.70235openalex-snapshot
UK recommendations for Ki‐67 immunohistochemical staining and interpretation in breast cancer
inferred← citeshttps://doi.org/10.1177/17588359221122725openalex-snapshot
Clinical validity and clinical utility of Ki67 in early breast cancer
inferred← citeshttps://doi.org/10.1186/s12915-024-01980-4openalex-snapshot
Flow cytometric analysis for Ki67 assessment in formalin-fixed paraffin-embedded breast cancer tissue
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1222719openalex-snapshot
Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy
inferred← citeshttps://doi.org/10.3390/biom11111612openalex-snapshot
Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
inferred← citeshttps://doi.org/10.3390/diagnostics13193105openalex-snapshot
Use of a Novel Deep Learning Open-Source Model for Quantification of Ki-67 in Breast Cancer Patients in Pakistan: A Comparative Study between the Manual and Automated Methods
inferred← citeshttps://doi.org/10.3390/diagnostics14151584openalex-snapshot
Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas
inferred← citeshttps://doi.org/10.3390/math13030417openalex-snapshot
RMD-Net: A Deep Learning Framework for Automated IHC Scoring of Lung Cancer IL-24
inferred← citeshttps://doi.org/10.6084/m9.figshare.26829014openalex-snapshot
Additional file 1 of Flow cytometric analysis for Ki67 assessment in formalin-fixed paraffin-embedded breast cancer tissue
inferred← citeshttps://doi.org/10.6084/m9.figshare.26829077openalex-snapshot
Additional file 2 of Flow cytometric analysis for Ki67 assessment in formalin-fixed paraffin-embedded breast cancer tissue
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.